A Phase 1b/2 Study of MEDI4736 With Tremelimumab, MEDI4736 or Tremelimumab Monotherapy in Gastric or GEJ Adenocarcinoma

Clinical trial NCT02340975 · COMPLETED

Trial details

NCT number: NCT02340975
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gastric or Gastroesophageal Junction Adenocarcinoma

Start date: 2015-03-31
Primary completion: 2019-04-29
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.